Cargando…
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
BACKGROUND: The clinical trials conducted at Chingleput India suggest that BCG fails to protect against tuberculosis (TB) in TB-endemic population. Recent studies advocate that non-tuberculous mycobacteria and latent Mycobacterium tuberculosis (Mtb) infection interferes in the antigen processing and...
Autores principales: | Rai, Pradeep K., Chodisetti, Sathi Babu, Maurya, Sudeep K., Nadeem, Sajid, Zeng, Weiguang, Janmeja, Ashok K., Jackson, David C., Agrewala, Javed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180631/ https://www.ncbi.nlm.nih.gov/pubmed/30305097 http://dx.doi.org/10.1186/s12967-018-1653-x |
Ejemplares similares
-
A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host
por: Rai, Pradeep K, et al.
Publicado: (2016) -
A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
por: Rai, Pradeep K., et al.
Publicado: (2017) -
CD40 Signaling Synergizes with TLR-2 in the BCR Independent Activation of Resting B Cells
por: Jain, Shweta, et al.
Publicado: (2011) -
Combinatorial Signaling through TLR-2 and CD86 Augments Activation and Differentiation of Resting B Cells
por: Jain, Shweta, et al.
Publicado: (2013) -
Correction: Combinatorial Signaling through TLR-2 and CD86 Augments Activation and Differentiation of Resting B Cells
por: Jain, Shweta, et al.
Publicado: (2014)